| Security | Market Valueª | Shares or Principal | Investment
Discretion | Other
Managersº | Voting Authority |
|---|
| Issuer Name | Issue Class | Opt. | CUSIP/CINS | $1000s | Weight | Amount | S/P | Price | Sole | Shared | None |
|---|
 | | | | | | | | | ↓List | (S/P Amounts or For All) |
|---|
|
| ACADIA HEALTHCARE COMPANY IN | COM | – | 00404A·10·9 | 16,903 | 1.86% | 510,666 | Sh. | 33.10 | Sole | – | Sole | – | – |
| ADMA BIOLOGICS INC | COM | – | 000899·10·4 | 6,523 | 0.72% | 1,273,933 | Sh. | 5.12 | Sole | – | Sole | – | – |
| AMAG PHARMACEUTICALS INC | COM | – | 00163U·10·6 | 35,736 | 3.92% | 1,026,902 | Sh. | 34.80 | Sole | – | Sole | – | – |
| AMARIN CORP PLC | SPONS ADR NEW | – | 023111·20·6 | 77,161 | 8.47% | 25,052,380 | Sh. | 3.08 | Sole | – | Sole | – | – |
| ANI PHARMACEUTICALS INC | COM | – | 00182C·10·3 | 29,801 | 3.27% | 491,608 | Sh. | 60.62 | Sole | – | Sole | – | – |
| ARIAD PHARMACEUTICALS INC | COM | – | 04033A·10·0 | 44,211 | 4.86% | 3,553,943 | Sh. | 12.44 | Sole | – | Sole | – | – |
| ARRAY BIOPHARMA INC | COM | – | 04269X·10·5 | 23,912 | 2.63% | 2,723,471 | Sh. | 8.78 | Sole | – | Sole | – | – |
| ATRICURE INC | COM | – | 04963C·20·9 | 52,181 | 5.73% | 2,666,354 | Sh. | 19.57 | Sole | – | Sole | – | – |
| BIOLASE INC | COM | – | 090911·10·8 | 2,029 | 0.22% | 1,449,022 | Sh. | 1.40 | Sole | – | Sole | – | – |
| CLOVIS ONCOLOGY INC | COM | – | 189464·10·0 | 121,306 | 13.32% | 2,730,887 | Sh. | 44.42 | Sole | – | Sole | – | – |
| GLOBUS MED INC | CL A | – | 379577·20·8 | 46,165 | 5.07% | 1,860,000 | Sh. | 24.82 | Sole | – | Sole | – | – |
| HORIZON PHARMA PLC | SHS | – | G4617B·10·5 | 93,745 | 10.30% | 5,793,903 | Sh. | 16.18 | Sole | – | Sole | – | – |
| MALLINCKRODT PUB LTD CO | SHS | – | G5785G·10·7 | 57,489 | 6.31% | 1,153,944 | Sh. | 49.82 | Sole | – | Sole | – | – |
| MEDNAX INC | COM | – | 58502B·10·6 | 43,996 | 4.83% | 660,000 | Sh. | 66.66 | Sole | – | Sole | – | – |
| MERRIMACK PHARMACEUTICALS IN | COM | – | 590328·10·0 | 36,997 | 4.06% | 9,067,998 | Sh. | 4.08 | Sole | – | Sole | – | – |
| MYRIAD GENETICS INC | COM | – | 62855J·10·4 | 38,823 | 4.26% | 2,328,932 | Sh. | 16.67 | Sole | – | Sole | – | – |
| NOVADAQ TECHNOLOGIES INC | COM | – | 66987G·10·2 | 17,109 | 1.88% | 2,413,179 | Sh. | 7.09 | Sole | – | Sole | – | – |
| PACIRA PHARMACEUTICALS INC | COM | – | 695127·10·0 | 20,407 | 2.24% | 631,805 | Sh. | 32.30 | Sole | – | Sole | – | – |
| RETROPHIN INC | COM | – | 761299·10·6 | 52,477 | 5.76% | 2,772,156 | Sh. | 18.93 | Sole | – | Sole | – | – |
| SEASPINE HLDGS CORP | COM | – | 81255T·10·8 | 1,012 | 0.11% | 128,127 | Sh. | 7.90 | Sole | – | Sole | – | – |
| UNITED THERAPEUTICS CORP DEL | COM | – | 91307C·10·2 | 83,290 | 9.15% | 580,701 | Sh. | 143.43 | Sole | – | Sole | – | – |
| VERACYTE INC | COM | – | 92337F·10·7 | 362 | 0.04% | 46,752 | Sh. | 7.74 | Sole | – | Sole | – | – |
| VERICEL CORP | COM | – | 92346J·10·8 | 8,949 | 0.98% | 2,982,940 | Sh. | 3.00 | Sole | – | Sole | – | – |
| — 23 Issuers — | — 23 Issues — | — 23 Holdings: $910,584,000 — | — Sole Manager — |
____________
ª No market value of any Holding was adjusted.
º Other Included Managers with whom investment discretion is shared as to any Holding: No Other Included Managers |
|
